BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1893971)

  • 1. Cooperative effects of hemin and anthracyclines in promoting terminal erythroid maturation in K562 human erythroleukemia cells.
    Tsiftsoglou AS; Wong W; Tsamadou AI; Robinson SH
    Exp Hematol; 1991 Oct; 19(9):928-33. PubMed ID: 1893971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative morphological assessment of erythroblastic differentiation induced, in vitro, in human K562 leukemic cells.
    Broglio C; Dufer J; Joly P; Carpentier Y; Desplaces A
    Anal Cell Pathol; 1993 May; 5(3):135-46. PubMed ID: 8343432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of hemoglobin synthesis in human leukemic K 562 cells by adriamycin.
    Jeannesson P; Ginot L; Manfait M; Jardillier JC
    Anticancer Res; 1984; 4(1-2):47-51. PubMed ID: 6585178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
    Jeannesson P; Trentesaux C; Nyoung MN; Mayeux P; Jacquot R; Jardillier JC
    Leukemia; 1991 Jan; 5(1):14-8. PubMed ID: 1847982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid.
    Cioe L; McNab A; Hubbell HR; Meo P; Curtis P; Rovera G
    Cancer Res; 1981 Jan; 41(1):237-43. PubMed ID: 6934848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
    Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
    Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K562 erythroleukemia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation.
    Järvinen M; Andersson LC; Virtanen I
    J Cell Physiol; 1990 May; 143(2):310-20. PubMed ID: 1692028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
    Fuchs R; Schraml E; Leitinger G; Stelzer I; Allard N; Haas HS; Schauenstein K; Sadjak A
    Exp Cell Res; 2011 Oct; 317(16):2239-51. PubMed ID: 21781962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of commitment by K562 human erythroleukemia cells.
    Rowley PT; Ohlsson-Wilhelm BM
    Prog Clin Biol Res; 1985; 191():217-31. PubMed ID: 3863148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells.
    Morceau F; Chénais B; Gillet R; Jardillier JC; Jeannesson P; Trentesaux C
    Cell Growth Differ; 1996 Aug; 7(8):1023-9. PubMed ID: 8853898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease induction of hemoglobin synthesis but not terminal cell division in K562 cells.
    Scher W; Hellinger N; Waxman S
    Exp Hematol; 1985 Jan; 13(1):36-43. PubMed ID: 3882441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells.
    Nyoung MN; Trentesaux C; Aries A; Carpentier Y; Jardillier JC; Gorisse MC; Jeannesson P
    Anticancer Res; 1994; 14(3A):1203-8. PubMed ID: 8074473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-alpha.
    Li XF; Anderson J; Hutzler D; Roodman GD
    Exp Hematol; 1989 Dec; 17(11):1059-62. PubMed ID: 2555212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of AHSP synthesis in hemin-induced K562 cells and EPO-induced CD34(+) cells leads to alpha-globin precipitation, impairment of normal hemoglobin production, and increased cell death.
    Pinho FO; de Albuquerque DM; Olalla Saad ST; Costa FF
    Exp Hematol; 2008 Mar; 36(3):265-72. PubMed ID: 18179859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible effect of heme on the fate of DNA ligase activity extracted from differentiating mouse erythroleukemia cells.
    Scher BM; Scher W; Waxman S
    Cancer Res; 1988 Nov; 48(22):6278-84. PubMed ID: 3180046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimidox-mediated morphological changes during erythroid differentiation is associated with the stimulation of hemoglobin and F-cell production in human K562 cells.
    Iyamu EW; Adunyah SE; Elford HL; Fasold H; Turner EA
    Biochem Biophys Res Commun; 1998 Jun; 247(3):759-64. PubMed ID: 9647767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential hemoglobin synthesis in murine erythroleukemic cells: hemin effects.
    Zucker RM; Umlas ME; Decal DL; Whittington KB
    Cell Biochem Funct; 1987 Jan; 5(1):27-35. PubMed ID: 3469035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
    Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.